Cargando…
Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer
Autores principales: | Soh, C-L, McNeil, K, Owczarek, C M, Hardy, M P, Fabri, L J, Pearse, M, Delaine, C A, Forbes, B E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705894/ https://www.ncbi.nlm.nih.gov/pubmed/26625216 http://dx.doi.org/10.1038/bjc.2015.385 |
Ejemplares similares
-
Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer
por: Soh, C-L, et al.
Publicado: (2014) -
Impact of dietary incorporation of Spirulina (Arthrospira platensis) and exogenous enzymes on broiler performance, carcass traits, and meat quality
por: Pestana, J.M., et al.
Publicado: (2020) -
IGFBP7 remodels the tumor microenvironment of esophageal squamous cell carcinoma by activating the TGFβ1/SMAD signaling pathway
por: Li, Xiuqing, et al.
Publicado: (2022) -
DICER1 hotspot mutations in non-epithelial gonadal tumours
por: Witkowski, L, et al.
Publicado: (2013) -
Corrigendum to “Early pregnancy serum IGFBP-1 relates to lipid profile in overweight and obese women” [Heliyon 6 (8) (August 2020) Article e04788]
por: Mokkala, Kati, et al.
Publicado: (2020)